More about

Allergic Asthma

News
August 26, 2022
5 min read
Save

Single-dose immunotherapy improves outcomes among patients with cat allergies

A single dose of immunotherapy treatment prevented reductions in FEV1 among patients with cat allergies and mild asthma, according to a study published in The Journal of Allergy and Clinical Immunology.

News
August 08, 2022
2 min read
Save

Household size linked to allergic sensitization

Researchers found an association between larger households and higher naive regulatory T-cell levels, which in turn were associated with less allergic sensitization and disease at age 12 months, according to a study.

News
July 19, 2022
2 min read
Save

Associations between aeroallergens, negative birth outcomes remain unclear

Some patterns have emerged regarding the effects of aeroallergens on pregnant women with respiratory allergies, but the clinical importance of these patterns remains unclear, according to study results.

News
April 29, 2022
3 min read
Save

IL-3 plays immunoregulatory role in allergic asthma

The pro-inflammatory protein IL-3 appeared to regulate the burden of allergic asthma by inducing T regulatory cell response and reducing the proliferation of type 2 innate lymphoid cells, according to a study in Frontiers in Immunology.

News
April 05, 2022
3 min read
Save

Q&A: IL-13 protects patients with allergic asthma against effects of SARS-CoV-2 infection

The Th2 cytokine IL-13 appeared to play a significant role in protecting people with allergic asthma against the damaging effects of SARS-CoV-2 infection, according to a study published in Proceedings of the National Academy of Sciences.

News
February 22, 2022
3 min read
Save

House dust mite sublingual immunotherapy may be effective for allergic asthma

House dust mite sublingual immunotherapy tablets reduced inhaled corticosteroid use among patients with mild to moderate allergic asthma, according to a systematic review in The Journal of Allergy and Clinical Immunology: In Practice.

News
February 15, 2022
4 min read
Save

Omalizumab benefits patients with moderate to severe allergic asthma regardless of BMI

Omalizumab benefited patients with moderate to severe allergic asthma regardless of their BMI, according to a study published in Annals of Allergy, Asthma & Immunology.

News
November 30, 2020
1 min read
Save

Novel insights on trajectories of asthma over time, extrapulmonary comorbidities

In a new study, distinct longitudinal trajectories of asthma and allergies from childhood to middle age were associated with different profiles of extrapulmonary comorbidities and risk for COPD.

News
April 22, 2020
1 min read
Save

Leo Pharma, Oneness Biotech and Microbio Shanghai enter license agreement for FB825

Leo Pharma, Oneness Biotech and Microbio Shanghai have entered into a worldwide exclusive licensing agreement for FB825, a novel atopic dermatitis and allergic asthma drug candidate, according to a press release.

View more